Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

The pharmaceutical and life sciences sector is undergoing sustained transformation driven by leadership, collaboration, and specialised talent. This edition highlights the forces propelling innovation and the mechanisms shaping the industry’s present and future. Strong leadership continues to shape the future of Ireland’s pharmaceutical sector. ‘Colin Rooney was named Pharma Leader of the Year' at the recently concluded Pharma Industry Awards 2025, demonstrating how strong leadership can drive sustainable growth across the sector. His recognition underscores the value of clear direction in advancing the next wave of innovators in 2026. Meanwhile, 'SGS strengthens Ireland’s lab talent pipeline' to support the growing life sciences sector demonstrates the importance of investing in skills and expertise. By equipping professionals with advanced capabilities, the industry remains agile amid evolving scientific, technological, and regulatory demands. Lastly, 'Frankfurt Airport strengthens global Pharma logistics' through Pharma.Aero partnership highlights the need for global collaboration and efficient infrastructure to ensure timely delivery of essential therapies while upholding quality and environmental standards. These developments underscore a core principle: resilience and growth rely on the convergence of leadership, talent, and strategic networks, offering both insight and optimism for the sector’s future.

Author: Business Wire

Meiji Seika Pharma invests in Lyric Bio to advance innovative IVIg biomanufacturing, supporting donor-independent production, accelerating R&D, and strengthening global supply of high-quality plasma-derived therapeutics.

Author: Jed Nykolle Harme

Colin Rooney was named Pharma Leader of the Year at the Pharma Industry Awards 2025 for his long-standing contribution to pharmaceutical manufacturing. His win sets a high bar for the next awards in 2026, shaping expectations for the next generation of sector leaders.

Author: Jed Nykolle Harme

Ireland’s life sciences sector is expanding rapidly, and the demand for skilled laboratory professionals continues to rise. To help meet this need, SGS ISL is working with IBEC and Munster Technological University (MTU) to strengthen the national Laboratory Apprenticeship Programme.

Author: Logistics Update Africa

Frankfurt Airport joins Pharma.Aero, enhancing global pharma logistics with expertise in temperature-sensitive cargo, strengthening supply chains, collaboration, and innovation to ensure reliable, high-quality transportation of life-saving healthcare products.

Author: University of Strathclyde Glasgow

Ireland’s pharma and biotech sector employs 8,200 tech professionals, with AI, digital therapeutics, and regulatory technology driving growth, high salaries, and strong investment, positioning the country as a European life sciences hub.

Author: Digital Health

Irish life sciences and health tech companies hit a decade-high €491.3m in 2024 across 89 VC deals, with FIRE1 leading late-stage funding and Enterprise Ireland driving innovation.

Author: Jed Nykolle Harme

The pharma and life sciences sector is undergoing accelerated transformation, driven by scientific progress, shifting markets and a renewed focus on equitable innovation. This edition reflects that momentum, highlighting how leading organisations are redefining their roles within a fast-changing landscape. First, the recognition of ‘Bristol Myers Squibb Wins Pharma Industry Company of the Year at the Pharma Industry Awards 2025’ underscores a sector raising its performance standards. The accolade shows how strategic investment, pipeline development and operational discipline are reinforcing long-term competitiveness. Market dynamics are also evolving. ‘Eli Lilly reaches the trillion dollar milestone as weight loss drugs reshape pharma’ signals how breakthrough treatments are recalibrating valuation models and reshaping expectations for innovation and commercial agility. Workplace leadership continues to shift. ‘EmpowHER: Women Driving Change and Innovation at SGS Pharma’ demonstrates how talent diversification is becoming essential to organisational strength. Inclusive leadership is broadening the industry's capacity to respond to complex health needs. Each piece in this edition traces a sector redefining its direction while keeping sight of sustainable, patient-centred progress. Readers are encouraged to explore these developments for deeper insight into the forces shaping pharma’s future.

Author: Jed Nykolle Harme

Bristol Myers Squibb was named Pharma Industry Company of the Year at the recently concluded Pharma Industry Awards 2025, setting benchmarks for innovation and inspiring entries for 2026.

Author: Jed Nykolle Harme

Women at SGS are leading the way in pharmaceutical innovation, combining expertise, leadership, and collaboration to shape the future of the life sciences industry. At SGS Pharma, diversity and inclusion are more than guiding principles, they are drivers of scientific excellence.